Evaluation of real-world early response of DMO to aflibercept therapy to inform future clinical trial design of novel investigational agents. (2020)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1038/s41598-020-73571-6
PubMed Identifier: 33020570
Publication URI: http://europepmc.org/abstract/MED/33020570
Type: Journal Article/Review
Volume: 10
Parent Publication: Scientific reports
Issue: 1
ISSN: 2045-2322